Experienced matrix leader in product development, I support Pharma, Biotech, Medtech, Start-up and Investment Companies in optimizing the strategic and operational management of their asset portfolio to maximize patient access to innovative therapeutic solutions. I provide expertise in defining and executing candidate development strategies along with portfolio, program, project, and alliance management services through tailored […]
Ray Stevens is a biotech executive, company builder, and drug development operator with experience across CMC, IND strategy, translational development, clinical planning, commercialization, financing, and fundraising strategy. He helps early and mid stage life sciences companies convert complex science into credible, executable development plans. Ray works with teams to clarify the next highest value experiment, […]
I’ve spent 30 years in medtech and biotech—from the bench to the production floor to the C-suite—bringing more than 25 products to market across FDA 510(k), CE/MDR, and TGA pathways. I’ve seen exceptional science fail, not because the innovation wasn’t strong, but because the operational, regulatory, and governance foundations weren’t in place to support commercialization. […]
I am a QA/QMS consultant with over 22 years of experience in GMP biotech and pharmaceutical environments, supporting companies to design, remediate, and scale inspection-ready Quality Management Systems. My expertise spans sterile and aseptic operations, Annex 1 readiness, audit and inspection leadership, and end-to-end lifecycle quality from deviations and CAPA to validation and product release. […]
Healthcare executive and scientist with 25+ years of leadership in biotechnology, focused on turning scientific innovation into commercial and clinical impact. Proven track record advancing first-in-class therapies and diagnostics, securing FDA clearances, and driving growth across public and private companies—including generating $10M+ in oncology revenue, expanding diagnostic portfolios, and managing a $30M P&L. Currently Chief […]
I have over 30 years of experience in small molecule and biologic drug discovery and development across Europe and the USA, with extensive expertise in regulatory filings and project management within both biotech and large pharmaceutical companies. I believe in empowering teams to focus on their strengths without distraction, a leadership approach that has made […]